57 related articles for article (PubMed ID: 26981377)
1. Gene expression profiling of Ctr9-regulated transcriptome in ERα-positive breast cancer.
Zeng H; Xu W
Genom Data; 2016 Mar; 7():103-4. PubMed ID: 26981377
[TBL] [Abstract][Full Text] [Related]
2. Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis.
Zeng H; Xu W
Genes Dev; 2015 Oct; 29(20):2153-67. PubMed ID: 26494790
[TBL] [Abstract][Full Text] [Related]
3. Systematic identification of Ctr9 regulome in ERα-positive breast cancer.
Zeng H; Lu L; Chan NT; Horswill M; Ahlquist P; Zhong X; Xu W
BMC Genomics; 2016 Nov; 17(1):902. PubMed ID: 27829357
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulator CTR9 inhibits Th17 differentiation via repression of IL-17 expression.
Yoo HS; Choi Y; Ahn N; Lee S; Kim WU; Jang MS; Jang MH; Kim YS; Yoo JY
J Immunol; 2014 Feb; 192(4):1440-8. PubMed ID: 24420920
[TBL] [Abstract][Full Text] [Related]
5. Ctr9, a Key Component of the Paf1 Complex, Affects Proliferation and Terminal Differentiation in the Developing Drosophila Nervous System.
Bahrampour S; Thor S
G3 (Bethesda); 2016 Oct; 6(10):3229-3239. PubMed ID: 27520958
[TBL] [Abstract][Full Text] [Related]
6. Proteome analysis of a CTR9 deficient yeast strain suggests that Ctr9 has function(s) independent of the Paf1 complex.
Massoni-Laporte A; Perrot M; Ponger L; Boucherie H; Guieysse-Peugeot AL
Biochim Biophys Acta; 2012 May; 1824(5):759-68. PubMed ID: 22446411
[TBL] [Abstract][Full Text] [Related]
7. Cln 3-requiring 9 is a negative regulator of Th17 pathway-driven inflammation in anti-glomerular basement membrane glomerulonephritis.
Lee H; Lee JW; Yoo KD; Yoo JY; Lee JP; Kim DK; Chin HJ; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F505-19. PubMed ID: 27306982
[TBL] [Abstract][Full Text] [Related]
8. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
[TBL] [Abstract][Full Text] [Related]
9. Drosophila CG2469 Encodes a Homolog of Human CTR9 and Is Essential for Development.
Chaturvedi D; Inaba M; Scoggin S; Buszczak M
G3 (Bethesda); 2016 Dec; 6(12):3849-3857. PubMed ID: 27678520
[TBL] [Abstract][Full Text] [Related]
10. Paf1 and Ctr9 subcomplex formation is essential for Paf1 complex assembly and functional regulation.
Xie Y; Zheng M; Chu X; Chen Y; Xu H; Wang J; Zhou H; Long J
Nat Commun; 2018 Sep; 9(1):3795. PubMed ID: 30228257
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of WDR5 regulated genes in bladder cancer.
Chen X; Gu P; Li K; Xie W; Chen C; Lin T; Huang J
Genom Data; 2015 Sep; 5():27-9. PubMed ID: 26484217
[TBL] [Abstract][Full Text] [Related]
12. SPEN, a new player in primary cilia formation and cell migration in breast cancer.
Légaré S; Chabot C; Basik M
Breast Cancer Res; 2017 Sep; 19(1):104. PubMed ID: 28877752
[TBL] [Abstract][Full Text] [Related]
13. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
16. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
Belguise K; Guo S; Sonenshein GE
Cancer Res; 2007 Jun; 67(12):5763-70. PubMed ID: 17575143
[TBL] [Abstract][Full Text] [Related]
17. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional elongation factor Paf1 core complex adopts a spirally wrapped solenoidal topology.
Deng P; Zhou Y; Jiang J; Li H; Tian W; Cao Y; Qin Y; Kim J; Roeder RG; Patel DJ; Wang Z
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):9998-10003. PubMed ID: 30224485
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
20. De novo non-synonymous CTR9 variants are associated with motor delay and macrocephaly: human genetic and zebrafish experimental evidence.
Suzuki H; Aoki K; Kurosawa K; Imagawa K; Ohto T; Yamada M; Takenouchi T; Kosaki K; Ishitani T
Hum Mol Genet; 2022 Nov; 31(22):3846-3854. PubMed ID: 35717577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
